ReviewThe Journal of nutrition2026
Bovine Leukemia Virus as a One Health Challenge in Nutrition, Food Security, and Public Health: A Narrative Review.
Review in The Journal of nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bovine leukemia virus (BLV) is among the most prevalent infectious diseases of dairy cattle, with herd-level infection rates exceeding 80% in many regions worldwide. Although only a minority of infected animals develop clinical enzootic bovine leukosis, subclinical effects are widespread and extend beyond animal health. This narrative review examines BLV through a One Health lens, emphasizing its nutritional, food security, and public health dimensions. Relevant literature was identified through targeted searches of major scientific databases using terms related to BLV, milk composition, nutrition, food security, and One Health. Evidence suggests that BLV infection reduces milk yield and alters composition, particularly in cows with high proviral load. Decreases in fat, protein, and bioactive components diminish milk's caloric density and functional quality, potentially lowering consumers' dietary intake of essential fatty acids, fat-soluble vitamins, and immunomodulatory proteins. Increased susceptibility to mastitis due to BLV-associated immune dysfunction further exacerbates nutrient losses, compounding inefficiencies in milk production. Collectively, these changes undermine dairy's nutritional value, especially for populations that rely heavily on milk as a staple food, including young children, low-income households, and communities in low- and middle-income countries where dairy products may provide important dietary energy, protein, and micronutrients. At the systems level, BLV contributes to economic inefficiency through reduced herd productivity. These losses aggregate into a significant drag on dairy supply, with implications for affordability, accessibility, and environmental sustainability. Although definitive evidence of zoonotic transmission is lacking, recurring detection of BLV deoxyribonucleic acid, proteins, and antibodies in human tissue raises questions regarding potential public health risks. Taken together, BLV represents an underappreciated One Health challenge, encompassing animal productivity, human nutrition, economic access, and possible zoonotic implications. Future research should quantify BLV's economic and nutritional impacts on consumers and clarify risks to human health to support interventions aligned with animal health, food security, and sustainable nutrition.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.